Scott Moomaw
Corporate Officer/Principal at LIQUIDIA CORPORATION
Net worth: 2 M $ as of 31/03/2024
Profile
Scott Moomaw was the founder of RareGen LLC, a company founded in 2018, where he held the title of Chief Operating Officer from 2018 to 2020.
He is currently working at Liquidia Corp.
as the Chief Commercial Officer since 2020.
In his former positions, Mr. Moomaw worked at United Therapeutics Corp.
from 2011 to 2016 as the Associate Vice President-Marketing, and at OPKO Health, Inc. from 2016 to 2018 as the Vice President-Marketing.
Mr. Moomaw completed his undergraduate degree at Miami University and holds an MBA from the University of Michigan.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LIQUIDIA CORPORATION
0.20% | 12/04/2024 | 151,881 ( 0.20% ) | 2 M $ | 31/03/2024 |
Scott Moomaw active positions
| Companies | Position | Start |
|---|---|---|
| LIQUIDIA CORPORATION | Corporate Officer/Principal | 18/11/2020 |
Former positions of Scott Moomaw
| Companies | Position | End |
|---|---|---|
RareGen LLC
 RareGen LLC Miscellaneous Commercial ServicesCommercial Services RareGen LLC provides strategy, investment, and commercialization for rare disease pharmaceutical products. The company is headquartered in Durham, NC. | Founder | 01/11/2020 |
| OPKO HEALTH, INC. | Sales & Marketing | 01/08/2018 |
| UNITED THERAPEUTICS CORPORATION | Sales & Marketing | 01/05/2016 |
Training of Scott Moomaw
| Miami University | Undergraduate Degree |
| University of Michigan | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| OPKO HEALTH, INC. | Health Services |
| LIQUIDIA CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
RareGen LLC
RareGen LLC Miscellaneous Commercial ServicesCommercial Services RareGen LLC provides strategy, investment, and commercialization for rare disease pharmaceutical products. The company is headquartered in Durham, NC. | Commercial Services |
- Stock Market
- Insiders
- Scott Moomaw